Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

CytoDyn continues to report strong results from COVID-19 patients using Leronlimab

CytoDyn Inc (OTCQB: CYDY) President and CEO Nader Pourhassan and Bruce Patterson, M.D. and Chief Executive Officer and founder of IncellDx joined Steve Darling from Proactive Vancouver with news the company continues to see more impressive results from
COVID-19 patients who have received leronlimab under the FDA’s New Drug program.
Both Pourhassen and Patterson talk about some of those results and where these patients are being treated

Видео CytoDyn continues to report strong results from COVID-19 patients using Leronlimab канала Proactive
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
30 апреля 2020 г. 21:55:11
00:09:31
Proactive
Правообладателям
Жалоба
Комментарии
Другие видео канала
CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patientsCytoDyn sees impressive results with Leronlimab on very ill COVID-19 patientsTranslating a Recent Scientific Discovery about Covid-19 | Bruce Patterson M.D | TEDxTraverseCityTranslating a Recent Scientific Discovery about Covid-19 | Bruce Patterson M.D | TEDxTraverseCityDr. Isaac George Shares His Experience Recovering from COVID-19Dr. Isaac George Shares His Experience Recovering from COVID-195/13/20 Coronavirus (COVID 19) Grand Rounds - Stanford Department of Medicine5/13/20 Coronavirus (COVID 19) Grand Rounds - Stanford Department of MedicineLeronlimab, RANTES, COVID 19 Coronavirus Discussion with Dr. Bruce Patterson of IncellDX (LIVE Q&A)Leronlimab, RANTES, COVID 19 Coronavirus Discussion with Dr. Bruce Patterson of IncellDX (LIVE Q&A)Leronlimab Talk with Dr. Nader Pourhassan Director, President and CEOLeronlimab Talk with Dr. Nader Pourhassan Director, President and CEODr. Bruce Patterson talks monitoring of COVID-19 as it relates to disease course and therapy.Dr. Bruce Patterson talks monitoring of COVID-19 as it relates to disease course and therapy.CytoDyn updates on Type A meeting with FDA, gets nod from UK proceed with Phase 3 coronavirus trialCytoDyn updates on Type A meeting with FDA, gets nod from UK proceed with Phase 3 coronavirus trialThe COVID-19 Trials: Treatments Show PromiseThe COVID-19 Trials: Treatments Show PromiseCOVID-19 Insights: LeronlimabCOVID-19 Insights: LeronlimabTWIST: Special Guest Tim Grittani Analyzes $CYDY & MoreTWIST: Special Guest Tim Grittani Analyzes $CYDY & MorePlug Power CEO says fuels cells will soon dominate electric vehiclesPlug Power CEO says fuels cells will soon dominate electric vehiclesGilead's moving quickly with FDA for approval of coronavirus drug remdesivir: CEOGilead's moving quickly with FDA for approval of coronavirus drug remdesivir: CEOCramer: This biotech stock could be worth over $100 billion on an FDA approvalCramer: This biotech stock could be worth over $100 billion on an FDA approvalModerna Vaccine Safe and Effective - FDAModerna Vaccine Safe and Effective - FDA5 Major Points: Leronlimab, RANTES and COVID 19 Highlights With Dr. Bruce Patterson5 Major Points: Leronlimab, RANTES and COVID 19 Highlights With Dr. Bruce PattersonI was part of a clinical trial for COVID. | Leronlimab with CytoDyn Inc.I was part of a clinical trial for COVID. | Leronlimab with CytoDyn Inc.COVID-19 Recombinant Hyperimmune, LeronlimabCOVID-19 Recombinant Hyperimmune, LeronlimabWhy the U.S. banking system could be on the verge of another crisisWhy the U.S. banking system could be on the verge of another crisisEmperor Energy raises $1 million as it advances Judith Gas Field offshore VictoriaEmperor Energy raises $1 million as it advances Judith Gas Field offshore Victoria
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала